The Validation of ICBT Clinical Trial: Disease Stress Adjustment in Breast Cancer Patients

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorNational Health Research Institutes, Taiwan

About this trial

Breast cancer and its treatment can cause ongoing emotional distress, including anxiety, depressive symptoms, stress-related reactions, and difficulties adjusting to life after treatment. This study evaluates an 8-week Internet-based cognitive behavioral therapy (ICBT) program designed to support psychological adjustment and improve quality of life among adults with stage I-III breast cancer who have completed primary cancer treatment.

Approximately 100 participants will be randomly assigned to either an ICBT group or a control group. Participants in the ICBT group will receive treatment as usual together with the 8-week online program, while participants in the control group will receive treatment as usual alone during the main study period. The study will compare changes in anxiety, depressive symptoms, post-traumatic stress symptoms, and quality of life between the two groups.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 18-65 years.

Diagnosis of stage I-III breast cancer.

Completion of primary breast cancer treatment, including surgery, chemotherapy, radiation therapy, and/or targeted therapy. Participants currently receiving endocrine therapy are eligible.

Ability to read and write Chinese and to use a mobile application and the Internet.

Disqualifiers

Diagnosis of stage IV breast cancer.

Concurrent diagnosis of another type of cancer.

Currently receiving surgery, chemotherapy, radiation therapy, or targeted therapy for breast cancer.

Diagnosis of a psychiatric disorder within the past 6 months, including major depressive disorder, generalized anxiety disorder, or schizophrenia.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Internet-Based Cognitive Behavioral Therapy Program for Breast Cancer Survivors

    Behavioral

    An 8-week Internet-based cognitive behavioral therapy program delivered through a mobile application. The program includes psychoeducational content and exercises related to self-compassion, cognitive restructuring, emotional regulation, stress management, relaxation, mindfulness, and coping with cancer-related concerns.

  • Treatment as Usual (TAU)

    Other intervention

    Participants will continue to receive routine clinical care provided by their treating health care professionals. No additional Internet-based cognitive behavioral therapy will be provided during the main comparative study period.

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: ICBT Plus Treatment as UsualExperimental treatment 1 intervention
Group B: Treatment as Usual ControlActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Psychological Distress as Assessed by the Depression, Anxiety and Stress Scale-21

Psychological distress will be assessed using the 21-item Depression, Anxiety and Stress Scale (DASS-21), which includes depression, anxiety, and stress subscales. Each item is rated on a 4-point scale from 0 to 3. Higher scores indicate greater levels of psychological distress. Changes in scores will be compared between the ICBT and TAU groups.

Time frame
Baseline to Week 9

Secondary outcomes

1

Change in Depressive Symptoms as Assessed by the Patient Health Questionnaire-9

Depressive symptoms will be assessed using the 9-item Patient Health Questionnaire (PHQ-9). The total score ranges from 0 to 27, with higher scores indicating greater severity of depressive symptoms. Changes in scores will be compared between the ICBT and TAU groups.

Time frame
Baseline, Week 5, Week 9, and 3 months after the intervention period
2

Change in Post-Traumatic Stress Symptoms as Assessed by the Posttraumatic Diagnostic Scale for DSM-5

Post-traumatic stress symptoms will be assessed using the Posttraumatic Diagnostic Scale for DSM-5 (PDS-5). The scale assesses the severity of post-traumatic stress symptoms and associated distress and functional impairment. Higher scores indicate greater severity of post-traumatic stress symptoms.

Time frame
Baseline, Week 5, Week 9, and 3 months after the intervention period
3

Change in Life Satisfaction as Assessed by the Satisfaction With Life Scale

Life satisfaction will be assessed using the 5-item Satisfaction With Life Scale (SWLS). The total score ranges from 5 to 35, with higher scores indicating greater satisfaction with life.

Time frame
Baseline, Week 5, Week 9, and 3 months after the intervention period
4

Change in Insomnia Severity as Assessed by the Insomnia Severity Index

Insomnia severity will be assessed using the 7-item Insomnia Severity Index (ISI). The total score ranges from 0 to 28, with higher scores indicating greater insomnia severity.

Time frame
Baseline, Week 5, Week 9, and 3 months after the intervention period

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: